Creating new cancer models using tumor samples
CGMP MANUFACTURING OF LMB-2 IMMUNOTOXIN
['FUNDING_OTHER'] · LEIDOS BIOMEDICAL RESEARCH, INC. · NIH-10291506
This study is creating new cancer models using real tumor samples to help scientists learn more about different types of cancer and how they respond to treatments, so they can improve care for patients like you.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | LEIDOS BIOMEDICAL RESEARCH, INC. (nih funded) |
| Locations | 1 site (FREDERICK, UNITED STATES) |
| Trial ID | NIH-10291506 on ClinicalTrials.gov |
What this research studies
This research focuses on developing next-generation cancer models derived from actual tumor samples, which are annotated with important genomic and clinical data. These models will serve as a valuable resource for the scientific community, helping researchers better understand various types of cancers. The initiative involves collaboration with multiple laboratories to ensure a diverse range of tumor subtypes are represented. By collecting clinical data at the time of enrollment and tracking outcomes, the research aims to enhance the understanding of cancer biology and treatment responses.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with various types of malignant tumors, especially those with rare or underrepresented subtypes.
Not a fit: Patients with non-malignant conditions or those not diagnosed with cancer may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved cancer treatments by providing better models for testing therapies.
How similar studies have performed: Previous research has shown success in developing cancer models, indicating that this approach has the potential for meaningful advancements.
Where this research is happening
FREDERICK, UNITED STATES
- LEIDOS BIOMEDICAL RESEARCH, INC. — FREDERICK, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: DMITROVSKY, ETHAN — LEIDOS BIOMEDICAL RESEARCH, INC.
- Study coordinator: DMITROVSKY, ETHAN
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Cancers, neoplasm/cancer